Cargando…
Use of paliperidone palmitate half-yearly release in patients diagnosed with psychotic disorder: profile and satisfaction of use
INTRODUCTION: The lack of insight can be present among patients with a diagnosis of schizophrenia, which often results in lack of adherence to pharmacological treatments(1) and, subsequently, in treatment discontinuation and relapses(2). This vicious pattern leads to further clinical deterioration,...
Autores principales: | Andres-Olivera, P., Alvarez, A., Garzon, M. D. L. A., Gonzalez, R., Roncero, C., Jesús, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661181/ http://dx.doi.org/10.1192/j.eurpsy.2023.1327 |
Ejemplares similares
-
Differences of use between paliperidone palmitate 3 month and paliperidone palmitate 1 month in real practice, with psychotic patients
por: Escobedo-Aedo, P., et al.
Publicado: (2022) -
Accidental Overdose of Paliperidone Palmitate
por: Ojimba, Chiedozie, et al.
Publicado: (2019) -
Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia
por: Hargarter, L, et al.
Publicado: (2016) -
Paliperidone to Treat Psychotic Disorders
por: Minwalla, Hormazd D., et al.
Publicado: (2021) -
Different onset patterns of monthly paliperidone palmitate in hospitalised patient diagnosed with schizophrenia
por: Herrera-Sánchez, Javier, et al.
Publicado: (2021)